2023-04-13 11:24:03 ET
With a combination of innovative technologies and %Neurological experience this firm stands out in the %Bioscience market. And a targeted drug delivery to the brain compound efficacy can be enhanced while mitigating side effects.
%PsycheceuticalBioscience (OTC: ), a bioscience company dedicated to developing cutting-edge technologies for the next generation of %MentalHealthTreatments , was named in Life Sciences Review 's Top 10 Biotech Startups for 2023. Psycheceutical earned recognition for its significant progress in developing innovative patented delivery technologies that are intended to increase the safety and efficacy of psychedelic compounds.
The firm develops cutting-edge technologies to advance the safe and effective delivery of psychedelic pharmaceutical medicines. Powered by a team of FDA drug development veterans, biotechnology experts, and the top minds in the psychedelic industry, Psycheceutical is on a mission to commercialize its precision dosing technologies to provide affordable, life-saving treatments to anyone suffering from mental health disorders or central nervous system diseases.
Shares were trading at $0.1096 in morning trade.